PCRX · Pacira BioSciences, Inc.

$23.00 -0.18 (-0.78%) At close · Aug 14

Market Cap

$916.82M

39.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Frank Lee	Chief Executive Officer	$896,539	$688,500	$3,184,640	$9,607,331	$648,240	$919,097	$15,944,347
Kristen Williams	Chief Administrative Officer and Secretary	$519,262	$246,810	$2,606,742	—	$220,751	$15,609	$3,609,174
Daryl Gaugler	Executive Vice President, Commercial Operations	$511,808	$236,800	$2,606,742	—	$217,523	$20,833	$3,593,706
Jonathan Slonin	Chief Medical Officer	$535,000	$247,438	$1,717,324	$131,038	$227,295	$20,833	$2,878,928
Shawn M. Cross	Chief Financial Officer	$100,962	$48,563	$1,242,750	$1,347,228	—	$3,722	$2,743,225
Lauren Riker	Former Interim Chief Financial Officer	$374,560	$271,718	$612,605	—	$159,191	$20,833	$1,438,907
Charles A. Reinhart	Former Chief Financial Officer	$374,173	$172,258	$350,470	—	—	$387,643	$1,284,544
David Stack	Former Chief Executive Officer	$634,038	$2,188	—	—	—	$91,152	$727,378

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Stack	Former Chief Executive Officer	$941,387	$720,600	$1,266,798	$3,909,786	—	$39,520	$6,878,091
Kristen Williams	Chief Administrative Officer and Secretary	$501,018	$225,900	$424,203	$438,138	—	$11,602	$1,600,861
Jonathan Slonin	Chief Medical Officer	$490,225	$220,300	$424,203	$438,138	—	$20,347	$1,593,213
Daryl Gaugler	Executive Vice President, Commercial Operations	$501,673	$225,900	$387,400	$398,307	—	$20,347	$1,533,627
Charles A. Reinhart	Former Chief Financial Officer	$486,671	$219,100	$348,660	$358,477	—	$14,520	$1,427,428

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Stack	Former Chief Executive Officer	$910,108	$618,900	$1,276,885	$4,030,545	—	$14,902	$6,851,340
Daryl Gaugler	Executive Vice President, Commercial Operations	$469,942	$287,900	$766,131	$746,490	—	$20,933	$2,291,396
Kristen Williams	Chief Administrative Officer and Secretary	$457,046	$330,400	$587,961	$621,240	—	$12,188	$2,008,835
Jonathan Slonin	Chief Medical Officer	$463,500	$185,400	$587,961	$621,240	—	$20,933	$1,879,034
Charles A. Reinhart	Former Chief Financial Officer	$475,000	$290,000	$472,151	$498,495	—	$15,582	$1,751,228

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Stack	Chief Executive Officer	$831,966	$624,675	$1,088,181	$3,244,433	—	$17,173	$5,806,428
Max Reinhardt	President	$266,000	$140,000	—	$4,145,775	—	$23,263	$4,575,038
Kristen Williams	Chief Administrative Officer and Secretary	$479,231	$225,000	$243,824	$720,919	—	$23,743	$1,692,717
Roy Winston	Chief Clinical Officer	$408,654	$225,000	$243,824	$720,919	—	$13,403	$1,611,800
Charles A. Reinhart	Chief Financial Officer	$433,512	$195,000	$191,576	$560,952	—	$8,704	$1,389,744

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Stack	Chief Executive Officer	$807,695	$679,200	$1,088,181	$3,244,433	—	$16,409	$5,835,918
Kristen Williams	Chief Administrative Officer and Secretary	$458,962	$250,000	$302,006	$900,437	—	$23,651	$1,935,056
Charles A. Reinhart	Chief Financial Officer	$420,827	$220,000	$191,750	$571,706	—	$3,390	$1,407,673

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Stack	Chief Executive Officer	$784,187	$467,114	$1,790,100	$1,666,848	—	$10,668	$4,718,917
Kristen Williams	Chief Administrative Officer and Secretary	$432,500	$155,880	$486,200	$452,724	—	$420	$1,527,724
Charles A. Reinhart	Chief Financial Officer	$408,654	$147,240	$386,750	$360,121	—	$16,170	$1,318,935

Executive changes

Person	Role	Change	Effective	Filed
Thomas Wiggans	Class III director	Appointed	2026-06-09	2026-06-11
Samit Hirawat	Class III director	Appointed	2026-06-09	2026-06-11
Christopher J. Christie	Class III director	Appointed	2026-06-09	2026-06-11
Dr. Samit Hirawat	Class III director	Appointed	2026-01-27	2026-01-28
Alethia Young	Class II director	Appointed	2025-06-10	2025-06-13
Frank D. Lee	Class II director	Appointed	2025-06-10	2025-06-13
Marcelo Bigal	Class II director	Appointed	2025-06-10	2025-06-13
Laura Brege	Chair of the Board	Appointed	2025-01-28	2025-01-30
Andreas Wicki	member of the Board	Resigned	2025-01-28	2025-01-30
Paul J. Hastings	Chair of the Board of Directors	Resigned	2025-01-28	2025-01-30
Brendan Teehan	Chief Commercial Officer	Appointed	2025-01-21	2025-01-21
Shawn M. Cross	Chief Financial Officer	Appointed	2024-10-21	2024-10-21
Lauren Riker	interim Chief Financial Officer	Appointed	2024-10-01	2024-09-27
Gary Pace	Board of Directors	Retired	2024-06-30	2024-06-13
Frank D. Lee	member of the Board	Appointed	2024-01-02	2024-02-29
Frank D. Lee	chief executive officer	Appointed	2024-01-02	2024-02-29
Frank Lee	member of the Board	Appointed	2024-01-02	2023-12-21
Frank Lee	Chief Executive Officer	Appointed	2024-01-02	2023-12-21
Michael Yang	member of the Board	Appointed	2023-10-06	2023-10-10
Abraham Ceesay	member of the Board	Appointed	2023-10-06	2023-10-10
Marcelo Bigal	member of the Board	Appointed	2023-10-06	2023-10-10
Alethia Young	member of the Board	Appointed	2023-10-06	2023-10-10
David Stack	Chairman and Chief Executive Officer	Retired	—	2023-09-26
David Stack	Chairman and Chief Executive Officer	Retired	—	2023-09-26
David Stack	Class III director	Appointed	2023-06-13	2023-06-20

Key facts CIK 1396814 CUSIP 695127100 13F (30d) 234 filings 230 filers Visit website Investor relations